Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1385908rdf:typepubmed:Citationlld:pubmed
pubmed-article:1385908lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1385908lifeskim:mentionsumls-concept:C1956346lld:lifeskim
pubmed-article:1385908lifeskim:mentionsumls-concept:C0022252lld:lifeskim
pubmed-article:1385908lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:1385908lifeskim:mentionsumls-concept:C1254881lld:lifeskim
pubmed-article:1385908lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:1385908pubmed:issue3lld:pubmed
pubmed-article:1385908pubmed:dateCreated1992-8-20lld:pubmed
pubmed-article:1385908pubmed:abstractTextThe effect of a four weeks oral treatment with 100 mg isosorbide dinitrate (ISDN) daily on platelet function was evaluated in 40 patients (aged 40-65 years) with proven coronary artery disease. Isosorbide dinitrate decreased platelet reactivity to ADP (p less than 0.001), increased platelet sensitivity to PGI2 (p less than 0.01) while the production of TXB2 from exogenous arachidonic acid substrate and from endogenous substrate were both significantly reduced. Circulating platelet aggregates as measured by the Wu-test were markedly reduced (p less than 0.001) but there was little change in the plasma concentration of the platelet proteins beta-thromboglobulin and platelet factor 4. Overall, platelet activation correlated with smoking, hypertension and a family history of coronary artery disease. The reduced platelet activation seen during treatment with isosorbide dinitrate may contribute to the therapeutic benefit seen with this drug in patients with coronary artery disease.lld:pubmed
pubmed-article:1385908pubmed:languageenglld:pubmed
pubmed-article:1385908pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385908pubmed:citationSubsetIMlld:pubmed
pubmed-article:1385908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1385908pubmed:statusMEDLINElld:pubmed
pubmed-article:1385908pubmed:monthFeblld:pubmed
pubmed-article:1385908pubmed:issn0049-3848lld:pubmed
pubmed-article:1385908pubmed:authorpubmed-author:SinzingerHHlld:pubmed
pubmed-article:1385908pubmed:authorpubmed-author:FitschaPPlld:pubmed
pubmed-article:1385908pubmed:authorpubmed-author:O'GradyJJlld:pubmed
pubmed-article:1385908pubmed:authorpubmed-author:VirgoliniIIlld:pubmed
pubmed-article:1385908pubmed:authorpubmed-author:RauschaFFlld:pubmed
pubmed-article:1385908pubmed:issnTypePrintlld:pubmed
pubmed-article:1385908pubmed:day1lld:pubmed
pubmed-article:1385908pubmed:volume65lld:pubmed
pubmed-article:1385908pubmed:ownerNLMlld:pubmed
pubmed-article:1385908pubmed:authorsCompleteYlld:pubmed
pubmed-article:1385908pubmed:pagination323-35lld:pubmed
pubmed-article:1385908pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:meshHeadingpubmed-meshheading:1385908-...lld:pubmed
pubmed-article:1385908pubmed:year1992lld:pubmed
pubmed-article:1385908pubmed:articleTitleModification of platelet function by isosorbide dinitrate in patients with coronary artery disease.lld:pubmed
pubmed-article:1385908pubmed:affiliationWilhelm Auerswald-Atherosclerosis Research Group (ASF) Vienna, Austria.lld:pubmed
pubmed-article:1385908pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1385908pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1385908lld:pubmed